The IMPAACT network is funded by the National Institute of Allergy and Infectious Diseases (NIAID), the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health, all part of NIH. The P1107 study is conducted by the IMPAACT Network, in collaboration with the Center for International Blood and Marrow Transplant Research, StemCyte, and the NIAID-funded AIDS Clinical Trials Group.
Kidney transplantation from deceased donors with HIV to people living with both HIV and end-stage kidney disease is feasible and safe, investigators supported by the National Institutes of Health have found.
A research team led by Univ.-Prof. Dr. Florian Klein of the Institute of Virology of the University Hospital Cologne and the German Center for Infection Research (DZIF) has identified a new highly active antibody targeting HIV.
NIH experts have highlight that efforts to prevent new HIV transmissions in the United States must be accompanied by advances in addressing HIV-associated comorbidities to improve the health of people already living with HIV,
Researchers at the National Institutes of Health and their colleagues at Massachusetts General Hospital (MGH) in Boston report that the injectable hormone tesamorelin reduces liver fat and prevents liver fibrosis (scarring) in people living with HIV.
A National Institutes of Health analysis of the Infections that can affect the health of the pregnant woman, the pregnancy, and the baby after delivery.
Bill & Melinda Gates Foundation said there is need for improved quality of counseling and a range of contraceptive and HIV prevention options, so women can make informed decisions to protect their health and future.